JW Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

JW Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-101,630	Closed	-$1.52M	–	45
2016 Q2	$1.52M	Hold	101,630	–	–	1.21%	21
2016 Q1	$1.24M	Hold	101,630	–	–	0.81%	23
2015 Q4	$1.62M	Sell	101,630 -5,000	-5%	-$78.7K	0.6%	24
2015 Q3	$1.64M	Sell	106,630 -5,000	-4%	-$108K	0.59%	26
2015 Q2	$2.71M	Buy	111,630 +245	+0.2%	+$5.87K	0.83%	20
2015 Q1	$2.59M	Buy	111,385 +7,902	+8%	+$209K	1.12%	23
2014 Q4	$2.6M	Buy	+103,483	New	+$3.04M	1.95%	13

JW Asset Management's SGNT Position: Q3 2016 in Review

JW Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 101,630 shares — an estimated $1.52M sold.

JW Asset Management first reported a position in SGNT in Q4 2014 and held it in 7 quarters. The position peaked at $2.71M in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

JW Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
JW Asset Management sold 101,630 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.52M.
JW Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 7 quarters.
JW Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.71M in Q2 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on JW Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.